Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 PUFA for Idiopathic Oligoasthenoteratospermia
NCT03634644Phase 1Unknown
- Sponsor
- Jinling Hospital
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Jinling Hospital. Primary endpoint: sperm concentration at 40 days. Status: unknown.
Beyond the preview
Go deeper on NCT03634644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634644.